# Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

> **NCT01092481** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1580 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT01092481
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01-26
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 1580 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092481, "Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01092481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*